Murchinson’s Valion Bio VBIO Stock Holding History

Murchinson’s Portfolio VBIO Stock Details VBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.8K	Buy	+4,600	New	+$100K	0.01%	124

Other funds holding VBIO

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Murchinson's VBIO Position: Q2 2026 in Review

Murchinson opened a new position in Valion Bio (VBIO) in Q2 2026: 4,600 shares worth $59.8K. The stake represents 0.01% of the portfolio and ranks #124 among its holdings.

11 funds tracked by Wall St. Rank hold VBIO as of Q2 2026.

Murchinson held 4,600 shares of Valion Bio worth $59.8K as of Q2 2026.
Valion Bio was a new Murchinson position in Q2 2026.
Valion Bio made up 0.01% of Murchinson's portfolio in Q2 2026, its #124 holding.
11 funds tracked by Wall St. Rank held Valion Bio as of Q2 2026.

Based on Murchinson's 13F filing for Q2 2026, filed 14 Aug 2026.